Navigation Links
ePharmaSolutions To Acquire Global Patient Recruitment Firm Polaris BioPharma
Date:6/20/2012

CONSHOHOCKEN, Pa., June 20, 2012 /PRNewswire/ -- ePharmaSolutions announces the acquisition of Polaris BioPharma Consulting, a leading global patient recruitment and retention firm headquartered in Slough, UK.

ePharmaSolutions, a leading clinical services and technology solutions provider has acquired Polaris BioPharma Consulting to meet client demand for more "in-country" site feasibility and patient recruitment support on global clinical studies. This acquisition increases ePharmaSolutions' global bandwidth while expanding its core workforce with a team of experienced patient recruitment specialists in every major continent who can implement global projects at the local level.

"We have worked closely with Polaris over the last ten years on some very complex projects, and they have always delivered," stated Lance Converse, ePharmaSolutions' Founder and CEO.   "They have a wealth of knowledge of the regulatory, clinical and cultural landscape, from a local perspective, and have connections with varied regional referral sources to expedite study enrollment. This addition is integral to the company's continued growth."

Polaris Biopharma was founded in 1999 as a boutique patient recruitment and retention firm supporting global pharmaceutical companies.  Over the last 13 years, Polaris has grown to 20 local recruitment specialists in every continent providing in-country support on global recruitment campaigns.

"We are proud to be a part of ePharmaSolutions and committed to our collective mission to improve and accelerate clinical trials through empirical expertise in patient recruitment, compliance and retention," stated Sanjiv Kanwar, Polaris Biopharma's Managing Director.   "We can now fully leverage the data-driven technology assets ePharmaSolutions has developed with Polaris' global experience and regionally based recruitment specialists to provide Sponsors with high-impact, results-driven site feasibility and patient recruitment campaigns."

ePharmaSolutions and Polaris will be attending the Annual DIA Meeting in Philadelphia June 25th – 28th 2012 at booth 1427.

About ePharmaSolutions
ePharmaSolutions is a leading provider of technology-based clinical services that helps improve the way sites are selected, trained, activated and managed to exceed enrollment goals.  ePharmaSolutions won the 2009 Bio-IT World Award for best clinical trial technology and has activated and trained more than 260,000 clinical researchers in 120 countries for the top 20 pharmaceutical companies in the world.  ePharmaSolutions is headquartered in Philadelphia with offices in Slough, UK. For more information, visit www.epharmasolutions.com or email info@epharmasolutions.com

About Polaris Biopharma Consulting
Polaris Biopharma Consulting is a boutique patient recruitment and retention firm with over 20 regionally based recruitment specialists spanning each continent.   Polaris has helped large and mid-sized pharmaceutical companies and CROs develop and deploy hundreds of global feasibility, trial optimisation and patient recruitment programs in every major therapeutic area.  Polaris is headquartered in Slough, UK.   For more information visit www.polarisbpc.com or email info@polarisbpc.com


'/>"/>
SOURCE ePharmaSolutions
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Chandler Chicco Companies Acquires Haas & Health Partner Public Relations and SanCom Creative Communication Solutions, Creating Unrivalled Healthcare Communication Capability in Germany
2. S.E.D. Labs to be Acquired by Quest Diagnostics
3. Celtaxsys Acquires Clinical Stage Innate Immunity Drug for Inflammation
4. TrovaGene Acquires CLIA - Certified Laboratory
5. Sigma-Aldrich to Acquire BioReliance; Extending Its Reach into Biopharmaceutical Testing and Services
6. Elsevier Acquires QUOSA, Provider of Life Sciences Content Management and Workflow Productivity Solutions
7. LoneStar Heart Acquires Worldwide Exclusive Rights to New Class of Small Molecules That May Lead to New Treatments for Diabetes
8. inVentiv Health to Acquire SDI Promotional and Medical Audit Businesses From IMS Health
9. GeneThera, Inc. Acquires Applied Genetics, S.A.
10. Amgen to Acquire Micromet
11. Camelot Healthcare Training Institute Acquired by Medtech
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... ... May 23, 2017 , ... A recent survey conducted by ... and difficult to control weed in 12 categories of broadleaf crops, fruits and vegetables, ... scientists across the U.S. and Canada participated in the 2016 survey, the second conducted ...
(Date:5/23/2017)... ... May 22, 2017 , ... ... 2017 in San Diego, California, this August will feature high-level speakers on ... autonomous vehicles. , SPIE Optics and Photonics, the largest multidisciplinary optical sciences meeting ...
(Date:5/23/2017)... San Diego, CA (PRWEB) , ... May 23, 2017 , ... ... extracellular matrix of polymeric molecules, can cause diverse pathologies ranging from food poisoning and ... economic impact of biofilms is in the tens of billions of dollars per year, ...
(Date:5/22/2017)... ... 2017 , ... Baltimore biotech firm, PathSensors, announced that its ... developing and issuing recommendations to grow Maryland's biohealth industry and position the state ... , The recommendations are contained in a report from the Maryland ...
Breaking Biology Technology:
(Date:4/11/2017)... April 11, 2017 NXT-ID, Inc. (NASDAQ: ... company, announces the appointment of independent Directors Mr. Robin ... its Board of Directors, furthering the company,s corporate governance and ... Gino Pereira ... look forward to their guidance and benefiting from their considerable ...
(Date:4/5/2017)... , April 5, 2017 Today HYPR ... that the server component of the HYPR platform is ... providing the end-to-end security architecture that empowers biometric authentication ... HYPR has already secured over 15 million users across ... manufacturers of connected home product suites and physical access ...
(Date:4/3/2017)... April 3, 2017  Data captured by ... platform, detected a statistically significant association between ... to treatment and objective response of cancer ... to predict whether cancer patients will respond ... as well as to improve both pre-infusion potency ...
Breaking Biology News(10 mins):